Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 520 results for "warner chilcott"

69.5% Return Seen to Date on SmarTrend Warner Chilcott Call (W...

(SmarTrend(R) Spotlight via COMTEX News Network) -- SmarTrend identified an Uptrend for Warner Chilcott (NASDAQ:WCRX) on January 17th, 2013 at $13.53. In approximately 23 months, Warner Chilcott has returned 69.54% as of today's recent price of ... PredictWallStreet, 1 month ago

8-K/A - Warner Chilcott Ltd (0001620602) (Filer)

Document Format Files Seq Description Document Type Size 1 FORM 8-K/A d822647d8ka.htm 8-K/A 43564 2 EX-99.1 d822647dex991.htm EX-99.1 583802 3 EX-99.2 d822647dex992.htm EX-99.2 250910 Complete submission text file
 SEC Filings2 months ago

Polaris Adds Industry Veteran Vincze, Promotes Three Partners, Continues Expansion in Europe and Opens Fourth Office in Boston

PRWeb First, Polaris proudly announced that Steve Vincze has joined as the managing partner of its newest office, in Boston. Steve is an authority in the industry, bringing more than 20 years' experience in the regulatory compliance space. ...
 Industrial Info Financials2 days ago
[x]  

Inflammatory Bowel Diseases (IBD): World Drug Industry and Market 2015-2025

/PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue prospects What's the future of medicines for inflammatory bowel disease (IBD)? Those intestinal treatments ...
 Tutorial Finder3 days ago Research and Markets Adds Report: PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update  Individual.com1 month ago PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update  Individual.com1 month ago Research and Markets: PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update  TMC Net1 month ago
[x]  

Daily Digest: More on Archbishop of York's book 'On Rock or Sand?'

Times (online only) Article on the issues around the Archbishop of York laying hands on new bishops, states Dr John Sentamu, will ordain the Rev Libby Lane as the Bishop of Stockport on Monday. It states a week later, he will take the unprecedented ...
 Noodls3 days ago
BioSpace

Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings

PR Newswire Association LLC DUBLIN and IRVINE, Calif., Jan. 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) today announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting ...
 Insurance News Net1 week ago Durata Therapeutics : Actavis and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis' Pending Acquisition of Allergan and Record Dates for Shareholder Meetings  4 Traders1 week ago ACTAVIS : and Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period for Actavis Pending Acquisition of Allergan and Record Dates for Shareholder Meetings  4 Traders1 week ago Actavis to Acquire Allergan to Create Top 10 Global Growth Pharmaceutical Company with $23 Billion in Revenue  Pharmacy Times2 months ago
[x]  

Earnings and Business Update Scheduled for February 18th

DUBLIN, Jan. 12, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), in advance of the start of the 33rd Annual J.P. Morgan Healthcare Conference, today announced that based on a preliminary review of 2014 fourth quarter results it expects non-GAAP ...
 FiercePharma1 week ago Actavis Announces Exceptional Preliminary Fourth Quarter 2014 Performance  Insurance News Net1 week ago Actavis : Announces Exceptional Preliminary Fourth Quarter 2014 Performance  4 Traders1 week ago
[x]  

Ambitious Actavis joins JPMorgan news fray with Street-beating EPS

Actavis CEO Brent Saunders Actavis' ($ACT) fourth-quarter and full-year 2014 results won't be available until the middle of next month, but in the meantime, investors should expect big things, the company said Monday. Based on a preliminary ...
 FiercePharma1 week ago

IBD Management Plan Calls for More Holistic Care

As the growth of outpatient pharmacy continues, there is a need for the profession to become more educated about the chronic diseases that pose the greatest treatment challenges to the health care team. A case in point is irritable bowel disease ...
 Pharmacy Practice News2 weeks ago

Plunkett's Health Care Industry Almanac 2015: Health Care Industry Market Research, Statistics, Trends & Leading Companies

PLUNKETT'S HEALTH CARE INDUSTRY ALMANAC 2015 Key Findings: Plunkett Research lists top 500 companies in Health Care and name top trends changing the industry for the mid term. Key Features:Industry trends analysis, market data and competitive ...
 MarketResearch.com2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less